St. Louis, MO 的 心房顫動 臨床試驗
9 項針對 心房顫動 的研究正在 St. Louis（約 30 英里範圍內）及其周邊地點尋找參與者。開啟研究以查看參與資格及聯絡研究團隊的方式。
官方研究文本（英文）
正在為研究招募對象嗎？將此頁面置頂展示 — $99 / 30 天 →
The Rhythm Evaluation for AntiCoagulaTion With Continuous Monitoring of Atrial Fibrillation
招募中3 期
- Washington University School of Medicine, St Louis
The Fourth Left Atrial Appendage Occlusion Study
招募中
- St. Louis University,, St Louis
Surveillance Trial of the Apple Watch in Reliable Burden Assessment in Unseen Recurrence of Surgically Treated AF
招募中觀察性研究
- Washington University School of Medicine in St. Louis, St Louis
Study to evaLuate the effIcacy and Safety of abeLacimab in High-risk Patients With Atrial Fibrillation Who Have Been Deemed Unsuitable for Oral antiCoagulation (LILAC-TIMI 76)
招募中3 期
- Anthos Investigational site 9966, St Louis
- Anthos Investigational site 9825, St Louis
Tracking Results of Ablations to Combat AF Registry Generation 2
招募中觀察性研究
- Washington University School of Medicine, St Louis
Anticoagulation for New-Onset Post-Operative Atrial Fibrillation After CABG
招募中3 期
- Washington University School of Medicine, St Louis
Baseline Atrial Fibrosis Predicts Risk for Post-operative Atrial Fibrillation in Patients Undergoing Cardiac Surgery
招募中觀察性研究
- Washington University Barnes-Jewish Hospital, St Louis
Medtronic Terminate AF Study
招募中
- Washington University School of Medicine, St Louis
Anticoagulation in ICH Survivors for Stroke Prevention and Recovery
招募中3 期
- Barnes Jewish Hospital, St Louis
- Mercy Hospital South, St Louis
- Mercy Hospital St. Louis, St Louis
其他城市的 心房顫動 試驗
- New York City, NY21 項研究
- Cleveland, OH17 項研究
- Boston, MA17 項研究
- Atlanta, GA16 項研究
- Jonesboro, AR12 項研究
- Chicago, IL12 項研究
- Philadelphia, PA12 項研究
- Ann Arbor, MI11 項研究
- Columbus, OH10 項研究
- Cincinnati, OH10 項研究
- Pittsburgh, PA10 項研究
- Orlando, FL9 項研究
St. Louis 的其他研究
- 非小細胞肺癌73 項研究
- 乳癌64 項研究
- 轉移性癌症54 項研究
- 大腸直腸癌50 項研究
- 癌症（所有類型）46 項研究
- 前列腺癌46 項研究
- 肺癌39 項研究
- 卵巢癌38 項研究
- 胰臟癌33 項研究
- 子宮內膜癌29 項研究
- 頭頸部鱗狀細胞癌28 項研究
- 心臟衰竭26 項研究
資料來源：ClinicalTrials.gov，擷取日期 2026年10月6日。各研究自行設定資格標準；由研究團隊決定參與者資格。